Tscan Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +137.0% | +170.6% | +54.4% | +4.4% | -23.4% | -30.2% | |
| – | +114.6% | +388.5% | +80.9% | +14.4% | +83.4% | +22.6% | |
| – | +62.6% | +386.7% | +80.9% | – | – | – | |
| – | +7,042.8% | -127.6% | – | – | -71.3% | -459.7% | |
| – | +239.9% | +134.6% | -57.5% | -25.5% | +21.6% | +15.2% | |
| – | +239.9% | +134.6% | -57.5% | +1,338.1% | -13.4% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | -99.8% | – | – | – | |
| – | +0.0% | +0.0% | -1.1% | -100.0% | – | -100.0% | |
| – | -99.2% | +65,756.9% | -84.5% | +361.4% | +54.1% | -100.2% | |
| – | -133.1% | – | -131.6% | – | +240.2% | -158.0% | |
| – | – | – | – | – | – | – |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.